Transcatheter Tricuspid Valve Interventions: An Emerging Field

Area of Science:

• Cardiology
• Interventional Cardiology
• Medical Device Technology

Background:

• Severe tricuspid regurgitation (TR) significantly increases mortality risk.
• Many patients with severe TR are inoperable or face prohibitive surgical risks.
• There is a critical need for effective treatment options for these patients.

Purpose of the Study:

• To provide an updated overview of novel transcatheter tricuspid valve interventions (TTVI).
• To offer a clinical perspective on the current landscape of TTVI.
• To highlight potential challenges and future directions in the field.

Main Methods:

• Review of current literature on transcatheter tricuspid valve interventions.
• Categorization of TTVI into annuloplasty, coaptation devices, edge-to-edge techniques, and valve replacement.
• Analysis of early clinical outcomes and limitations.

Main Results:

• TTVI procedures offer percutaneous alternatives to surgery for severe TR.
• Early studies indicate promising results for TTVI.
• Long-term follow-up data for TTVI are currently limited.

Conclusions:

• Transcatheter tricuspid valve interventions represent a rapidly evolving field for managing severe TR in high-risk patients.
• Further large-scale studies and long-term follow-up are essential to establish the definitive efficacy and safety of TTVI.
• TTVI holds significant potential but requires continued investigation to optimize patient selection and procedural techniques.